| Catalog No. | Size | Price (USD) |
| 68204-H001-5 | 5 mg | $740.55 |
| 68204-H001-25 | 25 mg | $2,221.66 |
| 68204-H001-500 | 500 µg | $222.17 |
General Information
| Product name | Anti-FZD1/2/5/7/8 (Research Grade Vantictumab Biosimilar) |
| Species reactivity | Reacts with: Human |
| Specificity | FZD1/2/5/7/8 |
| Preparation | This product is a recombinant monoclonal antibody expressed from HEK293 cells. |
| Source | IgG2, Lambda |
| Purification | Protein A |
| Formulation | Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0 |
| Conjugate | Unconjugated |
| Endotoxin | ≦ 1 EU/mg |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Image / Experimental Information
| Image 1 Description | ≥95 % as determined by SDS-PAGE. |
| Image 1 Alt Text | Human FZD1/2/5/7/8-Vantictumab Enzyme linked immunosorbent assay (ELISA) 46157 |
| Image 1 URL | Source image |
| Image 2 Description | ≥95 % as determined by SDS-PAGE. |
| Image 2 Alt Text | Human FZD1/2/5/7/8-Vantictumab Enzyme linked immunosorbent assay (ELISA) 46158 |
| Image 2 URL | Source image |
title: Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma
authors: Xin Luo; Xiangyang Zhong; ...; Hongbo Guo
journal: Research
date: 2025-08-13
pmid: 40809457
doi: 10.34133/research.0828
cited_by_count: 0
techniques: Binding Assay; Confocal Microscopy; Expressing; Functional Assay; Inhibition; Labeling; Positive Control; Quantitative RT-PCR; RNA Sequencing; SPR Assay; Software; Western Blot
bioz_score: 93
